Abstract:Background: The nuclear receptor REV-ERB alpha (nuclear receptor subfamily 1, Group D member 1, NR1D1) is one of the essential components of the circadian clock which modulates cell proliferation, glucose metabolism, inflammation, and many other biological processes. Modulation of these processes are also relevant to cancer development. Previous studies have suggested that activation of REV-ERBa correlates with cancer cell senescence and death, but how REV-ERBa play roles in tumor progression require further elucidation. Methods: We investigated the expression of REV-ERB alpha in clinical samples by immunohistochemistry (IHC). REV-ERB alpha is downregulated by shorth hairpin RNA (shRNA). The gene expression level of each group was detected by Western blot analysis. The effects of REV-ERB alpha downregulation on apoptosis and cell cycles was assessed by flow cytometry assay. A549 cell growth curve under different treatments measured by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Cell invasion ability under different treatments was measured by Transwell assay. Immunostaining analysis was also used for evaluating the effects of downregulation of REV-ERB alpha on nuclear factor-kappa B (NF-kappa B). Results: Compared to 81.8% (54/66) of samples exhibiting a lower expression level of REV- ERB alpha in cancer tissue than in paired normal tissue, only 18.2% (12/66) were higher or equally expressed in lung cancer tissue. Furthermore, downregulation of REV-ERB alpha by RNA interference can significantly enhance the transcription of nuclear factor-kappa B (NF-kappa B), while the expression of p53 remained the same. Downregulation of REV-ERBa was also shown to stimulate the invasion and promote the proliferation of lung adenocarcinoma cell line A549. Conclusions: Our findings suggest that tumorigenesis and progression of lung carcinoma is relevant to downregulation or inhibition of REV-ERB alpha. This pathophysiological process also correlates with regulation of the NF-kappa B signaling pathway, indicating that REV-ERB alpha is a potential target of lung cancer therapy.

Functional Characterization of Circadian Nuclear Receptors REV-ERBα and REV-ERBβ in Human Osteosarcoma Cell Cultures

Retinoic Acid-Related Orphan Receptor Ror Beta, Circadian Rhythm Abnormalities And Tumorigenesis

Retinoic acid-related orphan receptor RORβ, circadian rhythm abnormalities and tumorigenesis (Review)

Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle

Rev-erbalpha2 mRNA encodes a stable protein with a potential role in circadian clock regulation

The nuclear receptor REV-ERBα integrates circadian clock and energy metabolism.

Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence

Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming

Integration of the nuclear receptor REV-ERBα linked with circadian oscillators in the expressions of Alas1, Ppargc1a, and Il6 genes in rat granulosa cells

The Pathophysiological Roles and Regulatory Mechanism of Retinoic Acid Receptor-related Orphan Receptors

Redundant Function of REV-ERBα and Β and Non-essential Role for BMAL1 Cycling in Transcriptional Regulation of Intracellular Circadian Rhythms

REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis

REV-ERBα Reduction is Associated with Clinicopathological Features and Prognosis in Human Gastric Cancer.

Rev-erbα inhibits proliferation by reducing glycolytic flux and pentose phosphate pathway in human gastric cancer cells

Circadian REV-ERBs Repress E4bp4 to Activate NAMPT-dependent NAD+ Biosynthesis and Sustain Cardiac Function

Rev-erbα Regulates Circadian Rhythms and StAR Expression in Rat Granulosa Cells As Identified by the Agonist GSK4112.

REV-ERBα Inhibits Osteoclastogenesis and Protects against Alveolar Bone Loss

Role of the circadian nuclear receptor REV-ERBα in dorsal raphe serotonin synthesis in mood regulation

Overexpression of the Circadian Clock Gene Rev-erbα Affects Murine Bone Mesenchymal Stem Cell Proliferation and Osteogenesis

Downregulation of REV-ERBα is Associated with the Progression of Lung Adenocarcinoma.

The nuclear receptor REV‐ERBα is required for the daily balance of carbohydrate and lipid metabolism